This marks AbbVie’s second major siRNA deal following its $1.4bn acquisition of ...
Artificial Intelligence (AI) is now used throughout clinical trials, from recrui...
Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled p...
The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emreli...
As pressure to comply with stringent environmental regulations mounts, could gre...
The US Food and Drug Administration (FDA) has accepted BioCryst Pharmaceuticals’...
Japan’s MHLW has approved Sarepta Therapeutics’ gene therapy Elevidys for treati...
Orphan drug developers face significant difficulties when navigating market acce...
The FDA has cleared the IND for Ensoma's EN-374, targeting X-linked chronic gran...
AI and machine learning can transform fragmented and unstructured healthcare dat...
US President Donald Trump has signed an executive order telling drugmakers to cu...
The European Commission (EC) has granted orphan drug designation to Biodexa Phar...
The Trump administration has introduced legislation outlining plans for deep cut...
Abeona’s deal value is in line with recent voucher sale transactions amid uncert...
This follows what appeared to be a generally positive data readout for belrestot...
